Literature DB >> 3593477

2'-Deoxy-3,7-dideazaguanosine and related compounds. Synthesis of 6-amino-1-(2-deoxy-beta-D-erythro-pentofuranosyl) and 1-beta-D-arabinofuranosyl-1H-pyrrolo[3,2-c]pyridin-4(5H)-one via direct glycosylation of a pyrrole precursor.

N S Girgis, H B Cottam, S B Larson, R K Robins.   

Abstract

The synthesis of two new analogs of 2'-deoxyguanosine, 6-amino-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-1H-pyrrolo[3,2-c] pyridin-4(5H)-one (8) and 6-amino-1-beta-D-arabinofuranosyl-1H-pyrrolo[3,2-c]-pyridin-4(5H)-one (13) has been accomplished by glycosylation of the sodium salt of ethyl 2-cyanomethyl-1H-pyrrole-3-carboxylate (4c) using 1-chloro-2-deoxy-3,5-di-O-p-toluoyl-alpha-D-erythro-pentofuranose( 5) and 1-chloro-2,3,5-tri-O-benzyl-alpha-D-arabinofuranose (9), respectively. The resulting blocked nucleosides, ethyl 2-cyanomethyl-1-(2-deoxy-3,5-di-O-p-toluoyl-beta-D-erythro- pentofuranosyl)-1H-pyrrole-3-carboxylate (6) and ethyl 2-cyanomethyl-1-(2,3,5-tri-O-benzyl-beta-D-arabinofuranosyl)- 1H-pyrrole-3-carboxylate, were ring closed with hydrazine to form 5-amino-6-hydrazino-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-1H- pyrrolo[3,2-c]-pyridin-4(5H)-one (7) and 5,6-diamino-1-(2,3,5-tri-O-benzyl-beta-D-arabinofuranosyl)-1H- pyrrolo[3,2-c]pyridin-4(5H)-one (11), respectively. Treatment of 7 with Raney nickel provided the 2'-deoxyguanosine analog 8 while reaction of 11 with Raney nickel followed by palladium hydroxide/cyclohexene treatment gave the 2'-deoxyguanosine analog 13. The anomeric configuration of 8 was assigned as beta by proton NMR, while that of 13 was confirmed as beta by single-crystal X-ray analysis of the deblocked precursor ethyl 2-cyanomethyl-1-beta-D-arabinofuranosyl-1H-pyrrole-3-carboxylate (10a).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3593477      PMCID: PMC340519          DOI: 10.1093/nar/15.3.1217

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  6 in total

1.  Indole and 4-aminoindole nucleosides.

Authors:  E Walton; F W Holly; S R Jenkins
Journal:  J Org Chem       Date:  1968-01       Impact factor: 4.354

2.  Purine nucleosides. XI. The synthesis of 2'-deoxy-9-alpha- and-beta-D-ribofuranosylpurines and the correlation of their anomeric structure with proton magnetic resonance spectra.

Authors:  M J Robins; R K Robins
Journal:  J Am Chem Soc       Date:  1965-11-05       Impact factor: 15.419

3.  Synthesis and antiviral/antitumor activities of certain 3-deazaguanine nucleosides and nucleotides.

Authors:  G R Revankar; P K Gupta; A D Adams; N K Dalley; P A McKernan; P D Cook; P G Canonico; R K Robins
Journal:  J Med Chem       Date:  1984-11       Impact factor: 7.446

4.  Synthesis and xanthine oxidase inhibitory analysis of 1H-pyrrolo[3,2-c]pyridine-4,6(5H,7H)-dione (3,7-dideazaxanthine) and two of its derivatives.

Authors:  S W Schneller; R S Hosmane; L B MacCartney; D A Hessinger
Journal:  J Med Chem       Date:  1978-09       Impact factor: 7.446

5.  Glycosylindoles. VII. Synthesis of 1-(D-beta-ribofuranosyl)indole.

Authors:  M N Preobrazhenskaya; M M Vigdorchik; N N Suvorov
Journal:  Tetrahedron       Date:  1967-12       Impact factor: 2.457

6.  Synthesis and biological activity of certain 6-substituted and 2,6-disubstituted 2'-deoxytubercidins prepared via the stereospecific sodium salt glycosylation procedure.

Authors:  H B Cottam; Z Kazimierczuk; S Geary; P A McKernan; G R Revankar; R K Robins
Journal:  J Med Chem       Date:  1985-10       Impact factor: 7.446

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.